Hideki Ueno, MD, PhD


Professor
Department of Microbiology
Global Health and Emerging Pathogens Institute
Icahn School of Medicine at Mount Sinai

Professor
Department of Immunology
Graduate School of Medicine, Kyoto University

Primary Investigator
Institute for the Advanced Study of Human Biology, Kyoto University

http://labs.icahn.mssm.edu/uenolab/dr-ueno/


Hideki Ueno, M.D, Ph.D. is a Professor at the Global Health and Emerging Pathogens Institute in the Department of Microbiology. With more than 15 years experience in human immunology, Dr. Ueno’s research focuses on the human adaptive immune system –  the major immunological protection mechanism in charge of generation and maintenance of antigen-specific immune responses. The major research topic in the past decade in the Dr. Ueno Laboratory has been the biology of human T follicular helper (Tfh) cells, a CD4+ T cell subset fundamental for the generation of antibody responses. His laboratory has identified functionally distinct subsets within blood circulating Tfh cells in humans. This seminal work has been cited more than 600 times. This work has led to their identification of cTfh1 cells in charge of antibody responses following seasonal influenza vaccination. The Dr. Ueno laboratory also identified multiple key factors and pathways promoting the differentiation of human Tfh cells, including the IL-12-STAT4 axis.

IDIGH Calendar

<<  <  July 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    1  2  3  4  5
  6  7  8  9101112
13141516171819
20212223242526
2728293031  

Latest IDIGH Publications

  1. Duffy, S. C., Srinivasan, S., Schilling, M. A., Stuber, T., Danchuk, S. N., Michael, J. S., Venkatesan, M., Bansal, N., Maan, S., Jindal, N., Chaudhary, D., Dandapat, P., Katani, R., Chothe, S., Veerasami, M., Robbe-Austerman, S., Juleff, N., Kapur, V. & Behr, M. A.
    (2020)
    .
    Reconsidering Mycobacterium bovis as a proxy for zoonotic tuberculosis: a molecular epidemiological surveillance study
    .
    The Lancet. Microbe
    ,
    vol
    .
    1
    ,
    p
    .
    e66-e73
    .
  2. Stallworthy, G., Dias, H. M. & Pai, M.
    (2020)
    .
    Quality of tuberculosis care in the private health sector
    .
    Journal of clinical tuberculosis and other mycobacterial diseases
    ,
    vol
    .
    20
    ,
    p
    .
    100171
    .
  3. Noël, K. C., Papenburg, J., Lacroix, J., Quach, C., O'Donnell, S., Gonzales, M., Willson, D. F., Gilfoyle, E., McNally, J. D., Reynolds, S., Kazzaz, Y., Kawaguchi, A., Sato, M., Kongkiattikul, L., Leteurtre, S., Dubos, F., Karaca, Y., Chiusolo, F., Piva, J., Dendukuri, N., Fontela, P. S. & Canadian Critical Care Trials Group (CCCTG) and the Pediatric Lung Injury and Sepsis Investigators (PALISI) Network.
    (2020)
    .
    International Survey on Determinants of Antibiotic Duration and Discontinuation in Pediatric Critically Ill Patients
    .
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
  4. Saha-Chaudhuri, P., Rabin, C., Tchervenkov, J., Baran, D., Morein, J. & Sapir-Pichhadze, R.
    (2020)
    .
    Predicting Clinical Outcome in Expanded Criteria Donor Kidney Transplantation: A Retrospective Cohort Study
    .
    Canadian journal of kidney health and disease
    ,
    vol
    .
    7
    ,
    p
    .
    2054358120924305
    .
  5. Ladouceur, A., Tessier-Cloutier, B., Clarke, A. E., Ramsey-Goldman, R., Gordon, C., Hansen, J. E. & Bernatsky, S.
    (2020)
    .
    Cancer and Systemic Lupus Erythematosus
    .
    Rheumatic diseases clinics of North America
    ,
    vol
    .
    46
    ,
    p
    .
    533-550
    .
More publications